Jie Qiao - Gynecology

Author Information

Dr. Jie Qiao is a prominent researcher affiliated with the Beijing Advanced Innovation Center for Genomics, Department of Obstetrics and Gynecology at the Third Hospital, College of Life Sciences, Peking University, Beijing, China. Her research primarily focuses on various aspects of gynecology, including in vitro fertilization, polycystic ovary syndrome, and oocyte maturation.

Research Contributions

Dr. Jie Qiao has made significant contributions to the field of gynecology. In 2022 alone, she has published numerous papers on diverse topics such as predicting fertilization disorders in IVF/ICSI, the severity of anemia during pregnancy, and the prevalence of polycystic ovary syndrome in China. Her research also delves into the molecular and metabolic processes involved in oocyte maturation and embryo development. Her work is not only extensive but also impactful, often providing valuable insights for both clinical applications and further research.

Aliases

J Qiao, J. Qiao, Jie Qiao

Publication and Citation Metrics

Metric	Value
Total Citation Count	20,462
h-index	69
Total Paper Count	624

Publications:

Prediction of Fertilization Disorders in the In Vitro Fertilization/Intracytoplasmic Sperm Injection: A Retrospective Study of 106,728 Treatment Cycles

DOI: 10.3389/fendo.2022.870708

Year: 2022

Severity of Anemia During Pregnancy and Adverse Maternal and Fetal Outcomes

DOI: 10.1001/jamanetworkopen.2021.47046

Year: 2022

A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study

DOI: 10.3389/fendo.2022.821368

Year: 2022

Correlation of LH level and steroid concentrations in GnRH antagonist protocol: A sub-analysis of Ganirelix phase III study of China.

DOI: 10.1016/j.jogoh.2022.102363

Year: 2022

Effect of vitrification on clinical outcomes of cleavage-stage embryos with poor quality in human embryo cryopreservation

DOI: 10.1097/RD9.0000000000000004

Year: 2022

Changes in the Prevalence of Polycystic Ovary Syndrome in China Over the Past Decade

DOI: 10.2139/ssrn.4048835

Year: 2022

The function of Nucleoporin 37 on mouse oocyte maturation and preimplantation embryo development

DOI: 10.1007/s10815-021-02330-x

Year: 2022

Lipid Metabolic Process Involved in Oocyte Maturation During Folliculogenesis

DOI: 10.3389/fcell.2022.806890

Year: 2022

In Vivo and In Vitro Matured Oocytes From Mice of Advanced Reproductive Age Exhibit Alternative Splicing Processes for Mitochondrial Oxidative Phosphorylation

DOI: 10.3389/fendo.2022.816606

Year: 2022

Live birth after letrozole as an adjunct to follicle-stimulating hormone versus follicle-stimulating hormone alone for ovarian stimulation in in vitro fertilisation cycles—study protocol for a randomised controlled trial

DOI: 10.1186/s13063-022-06185-0

Year: 2022

Does RAI affect breastfeeding?

Is Boric Acid Safe?

Can You Have a Vaginal Birth After a C-Section?

Can Hormone Replacement Therapy Improve Memory?

What Can a CT Scan Diagnose in Gynecology?

Are These Therapies Safe?

What Should Patients Do if Their Privacy is Compromised?

What Are the Risks of Organ Injury and How Are They Addressed?

Are There Any Certifications or Standards for Sustainable Gynecology?

What is Laparoscopic Supracervical Hysterectomy (LSH)?

Partnered Content Networks

Relevant Topics